ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc (CRNX)

40.59
-7.91
(-16.31%)
Closed 11 January 8:00AM
40.99
0.40
(0.99%)
After Hours: 10:07AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
40.99
Bid
40.00
Offer
43.54
Volume
3,030,947
40.04 Day's Range 47.56
35.24 52 Week Range 62.53
Market Cap
Previous Close
48.50
Open
46.64
Last Trade
1
@
41.99
Last Trade Time
Financial Volume
US$ 131,198,451
VWAP
43.2863
Average Volume (3m)
650,171
Shares Outstanding
92,737,627
Dividend Yield
-
PE Ratio
-17.53
Earnings Per Share (EPS)
-2.31
Revenue
4.01M
Net Profit
-214.53M

About Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Crinetics Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CRNX. The last closing price for Crinetics Pharmaceuticals was US$48.50. Over the last year, Crinetics Pharmaceuticals shares have traded in a share price range of US$ 35.24 to US$ 62.53.

Crinetics Pharmaceuticals currently has 92,737,627 shares in issue. The market capitalisation of Crinetics Pharmaceuticals is US$4.50 billion. Crinetics Pharmaceuticals has a price to earnings ratio (PE ratio) of -17.53.

CRNX Latest News

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2025, the Compensation Committee of the Board of Directors granted...

Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

Substantial, Rapid and Sustained Statistically Significant Reductions of Key Biomarkers Achieved Across Doses, Including up to 80% Mean Reduction of Androstenedione Meaningful Improvements...

Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics, will...

Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer

SAN DIEGO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the appointment of Isabel Kalofonos as Chief Commercial Officer. Ms. Kalofonos will...

Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on December 10, 2024, the Compensation Committee of the Board of Directors...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-10.85-20.929783950651.8453.5540.5663280850.18547768CS
4-14.48-26.104200468755.4756.26540.5673105952.61235448CS
12-17.92-30.41928365358.9162.5340.5665017155.93393821CS
26-7.47-15.414775072248.4662.5340.5667901054.02804824CS
523.348.8711819389137.6562.5335.2476458648.52274872CS
15615.4560.493343774525.5462.5315.2362050134.0356781CS
26014.4854.620897774426.5162.5310.6343960531.6361068CS

CRNX - Frequently Asked Questions (FAQ)

What is the current Crinetics Pharmaceuticals share price?
The current share price of Crinetics Pharmaceuticals is US$ 40.99
How many Crinetics Pharmaceuticals shares are in issue?
Crinetics Pharmaceuticals has 92,737,627 shares in issue
What is the market cap of Crinetics Pharmaceuticals?
The market capitalisation of Crinetics Pharmaceuticals is USD 4.5B
What is the 1 year trading range for Crinetics Pharmaceuticals share price?
Crinetics Pharmaceuticals has traded in the range of US$ 35.24 to US$ 62.53 during the past year
What is the PE ratio of Crinetics Pharmaceuticals?
The price to earnings ratio of Crinetics Pharmaceuticals is -17.53
What is the cash to sales ratio of Crinetics Pharmaceuticals?
The cash to sales ratio of Crinetics Pharmaceuticals is 936.72
What is the reporting currency for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Crinetics Pharmaceuticals?
The latest annual turnover of Crinetics Pharmaceuticals is USD 4.01M
What is the latest annual profit for Crinetics Pharmaceuticals?
The latest annual profit of Crinetics Pharmaceuticals is USD -214.53M
What is the registered address of Crinetics Pharmaceuticals?
The registered address for Crinetics Pharmaceuticals is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Crinetics Pharmaceuticals website address?
The website address for Crinetics Pharmaceuticals is www.crinetics.com
Which industry sector does Crinetics Pharmaceuticals operate in?
Crinetics Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.83M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.72M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.61M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.85M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.44M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M

Your Recent History

Delayed Upgrade Clock